"During the meeting, the FDA indicated that there are no outstanding substantive review issues with Telix’s submission".
Ann: Update on FDA New Drug Application Review for Illuccix, page-6
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.99 |
Change
0.130(0.57%) |
Mkt cap ! $7.694B | |||
| Open | High | Low | Value | Volume |
| $22.97 | $23.46 | $22.89 | $22.02M | 952.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3712 | $22.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $23.06 | 540 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |